Safety and immunogenicity of a cytomegalovirus (CMV) recombinant glycoprotein B (gB) vaccine in combination with polyacrylate or an emulsion-based adjuvants

Vaccine 2026

View at publisher
Authors: Sylvie Pichon, Isabelle Bruyère, Stéphane Janicot, Widad Silhadi, Sophie Pallardy, Ada-Maria Minutello, Yves Donazzolo, Mathilde Latreille, Laurent Beloeil, Nathalie Garçon, Anke Pagnon, Frédérique Jantet-Blaudez
+1 more Fabienne Piras-Douce
DOI: 10.1016/j.vaccine.2026.128553
Cited by: 1
References: 33

Fields of Study & Subjects

Cytomegalovirus and herpesvirus research Herpesvirus Infections and Treatments HIV Research and Treatment

Publication details

Journal / source
Vaccine
Publisher
Elsevier BV
Volume
80
Pages
128553–128553
Publication date
1 April 2026
Language
EN